Betaine (Cystadane)

Trade Name : Cystadane

Rare Disease Therapeutics, Inc.

POWDER, FOR SOLUTION

Strength 6 g/1

BETAINE Methylating Activity [MoA],Methylating Agent [EPC]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Betaine (Cystadane) which is also known as Cystadane and Manufactured by Rare Disease Therapeutics, Inc.. It is available in strength of 6 g/1 per ml. Read more

Betaine (Cystadane) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • Changes of Address u00a0 08/2008ntttAddress of adverse reactions u00a0 07/2010ntttChange of distributor u00a0 07/2014ntttManufactured For / Under License From u00a0 07/2014nttt
  • Cystadane is a methylating agent indicated for the treatment of homocystinuria to decrease elevated homocysteine blood levels.u00a0 Included within the category of homocystinuria are ():n
  • Cystathionine beta-synthase (CBS) deficiency
  • 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency
  • Cobalamin cofactor metabolism (cbl) defectn
  • ntttCystadaneu00ae (betaine anhydrous for oral solution) is indicated for the treatment of homocystinuria to decrease elevated homocysteine blood levels.u00a0 ntttIncluded within the category of homocystinuria are:u00a0u00a0 n
  • No data
  • Usual dose in adult and pediatric patients is 6 grams per day, administered orally in divided doses of 3 grams two times a day.()
  • In children less than 3 years of age, may initiate dosing at 100 mg/kg/day, divided in twice daily doses, and then increased weekly by 50 mg/kg increments.()
  • Dose can be gradually increased until plasma total homocysteine is undetectable or present only in small amounts.()
  • Monitor patient response by plasma homocysteine levels.()
  • Prescribed amount of Cystadane should be measured with the measuring scoop provided and then dissolved in 4 to 6 ounces of water, juice, milk, or formula, or mixed with food for immediate ingestion.()n
  • No data
  • No data
  • Powder for oral solution available in bottles containing 180 grams of betaine anhydrous.()n
  • Cystadane is a white, granular, hygroscopic powder for oral solution available in bottles containing 180 grams of betaine anhydrous.n n
  • No data
  • Nonen
  • None.n
  • No data
  • Hypermethioninemia:u00a0 Cystadane may worsen elevated plasma methionine concentrations in patients with CBS deficiency.u00a0 Cerebral edema has been reported in patients receiving Cystadane.()
  • Monitoring:u00a0 Monitor plasma methionine concentrations in patients with CBS deficiency.u00a0 Keep plasma methionine concentrations below 1,000 u00b5mol/L through dietary medication and, if necessary, a reduction of Cystadane dose. ()
  • nttttttttRisk of Hypermethioninemia in Patients with CBS DeficiencynttttttttPatients with homocystinuria due to cystathionine beta-synthase (CBS) deficiency may also have elevated plasma methionine concentrations.u00a0 nttttttttTreatment with Cystadane may further increase methionine concentrations due to the remethylation of homocysteine to methionine.ntttu00a0 tttttCerebral edema has been reported in patients with hypermethioninemia, including patients treated with Cystadane.u00a0 Plasma methionine concentrations should be monitored in patients with CBS deficiency.u00a0 nttttttttPlasma methionine concentrations should be kept below 1,000 u00b5mol/L through dietary modification and, if necessary, a reduction of Cystadane dose.ntttttttt
  • No data
  • Most common adverse reactions (incidence > 2%) were nausea and gastrointestinal distress, based on physician survey. n ntttntttTo report SUSPECTED ADVERSE REACTIONS, contact 877-828-8874, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
  • No data
  • No data
  • Pregnancy: Animal reproduction studies have not been conducted with Cystadane.u00a0 Use only if clearly needed.()
  • Nursing women: It is not known whether Cystadane is excreted in human milk.u00a0 Use only if clearly needed.()
  • Pediatrics: Pediatric patients ranging in age from 24 days to 17 years have been treated with Cystadane.u00a0 Children younger than 3 years of age may benefit from dose titration.
  • No data
  • In an acute toxicology study in rats, death occurred frequently at doses equal to or greater than 10 g/kg.n n
  • Cystadane (betaine anhydrous for oral solution) is an agent for the treatment of homocystinuria.u00a0 ntttIt contains no ingredients other than anhydrous betaine. Cystadane is a white, granular, hygroscopic powder, which is diluted in water and administered orally.u00a0 ntttThe chemical name of betaine anhydrous powder is trimethylglycine.u00a0 It has a molecular weight of 117.15.u00a0 ntttThe structural formula is:
  • No data
  • nttttttLong-term carcinogenicity and fertility studies have not been conducted with Cystadane.u00a0 nttttttNo evidence of genotoxicity was demonstrated in the following tests: metaphase analysis of human lymphocytes; bacterial reverse mutation assay; and mouse micronucleus test.ntttttt
  • Cystadane was studied in a double-blind, placebo-controlled, crossover study in 6 patients with CBS deficiency, ages 7 to 32 years at enrollment.u00a0 ntttCystadane was administered at a dosage of 3 grams twice daily, for 12 months. Plasma homocystine levels were significantly reduced (p<0.01) compared to placebo. ntttPlasma methionine levels were variable and not significantly different compared to placebo. No adverse events were reported in any patient.
  • Cystadane has also been evaluated in observational studies without concurrent controls in patients with homocystinuria due to CBS deficiency, MTHFR deficiency, or cbl defect.A review of 16 case studies and the randomized controlled trial previously described was also conducted, and the data available for each study were summarized; however, no formal statistical analyses were performed. nttttThe studies included a total of 78 male and female patients with homocystinuria who were treated with Cystadane. This included 48 patients with CBS deficiency, 13 with MTHFR deficiency, and 11 with cbl defect, ranging in age from 24 days to 53 years. The majority of patients (n=48) received 6 gm/day, 3 patients received less than 6 gm/day, 12 patients received doses from 6 to 15 gm/day, and 5 patients received doses over 15 gm/day. nttttMost patients were treated for more than 3 months (n=57) and 30 patients were treated for 1 year or longer (range 1 month to 11 years). Homocystine is formed nonenzymatically from two molecules of homocysteine, and both have be used to evaluate the effect of Cystadane in patients with homocystinuria. Plasma homocystine or homocysteine levels were reported numerically for 62 patients, and 61 of these patients showed decreases with Cystadane treatment. nttttHomocystine decreased by 83-88% regardless of pre-treatment level, and homocysteine decreased by 71-83%, regardless of the pre-treatment level. Clinical improvement, such as improvement in seizures, or behavioral and cognitive functioning, was reported by the treating physicians in about three-fourths of patients. Many of these patients were also taking other therapies such as vitamin B6 (pyridoxine), vitamin B12 (cobalamin), and folate with variable biochemical responses. nttttIn most cases, adding Cystadane resulted in a further reduction of either homocystine or homocysteine.
  • Cystadane is available in plastic bottles containing 180 grams of betaine anhydrous.u00a0 Each bottle is equipped with a plastic child-resistant cap and is supplied with a polystyrene measuring scoop.u00a0 One level scoop (1.7 mL) is equal to 1 gram of betaine anhydrous powder.
  • NDC 66621-4000-1u00a0u00a0u00a0 180 g/bottle
  • Cystadane can be ordered by calling AnovoRx Group, LLC, Customer service at 1-888-487-4703
  • Store at room temperature, 15 u2013 30 u02daC (59 u2013 86 u02daF).u00a0 Protect from moisture.
  • Patients should be advised of the following information before beginning treatment with Cystadane:
  • - Measure with the scoop provided.
  • - Measure the number of scoops as prescribed by their healthcare professional. One level scoop (1.7 mL) is equivalent to 1 gram of betaine anhydrous powder.
  • - Mix powder with 4 to 6 ounces (120 to 180 mL) of water, juice, milk, or formula until completely dissolved, or mix with food, then ingest mixture immediately.
  • - Always replace the cap tightly after using, and protect powder from moisture.n
  • Manufactured For:
  • Under License From:
  • Distributed By:
  • No data

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Dossiers and Stability Studies

Dossiers and Stability Studies

STABILITY STUDIES STABILITY, BA / BE STUDIES Due to our active

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71247 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.